Please assess the completion status of the following clinical trial:

Trial Title: Fish Oil-derived N-3 Polyunsaturated Fatty Acids and Extracellular Vesicles

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 40-70 years~* Non-smoker~* At moderate risk of cardiovascular diseases~  * The risk will be evaluated by an online calculator called QRISK2. This online calculator (https://qrisk.org/2016/), which use traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, will provide a percentage of risk of having a heart attack or stroke within the next 10 years.~ * Subjects with 10%-20% will be regarded as being at moderate risk~Exclusion Criteria:~* BMI: \<18.5 kg/m2~* Anaemia (haemoglobin concentration \<12.5 g/L in men and\<11.5 g/L in women)~* Hyperlipidaemia (total cholesterol concentration \>8 mmol/L)~* Diabetes (diagnosed or fasting glucose concentration \>7 mmol/L) or other endocrine disorders~* Angina, stroke, or any vascular disease in the past 12 months~* Renal, gastrointestinal, respiratory, liver or bowel disease~* Inflammatory disease~* Take drug treatment for hypertension, hyperlipidaemia, inflammation, depression or thyropathy.~* Take aspirin, ibuprofen or other nonsteroidal anti-inflammatory drugs (NSAIDs) \> 4 times per month, or once in the week preceding the study~* Take any other anti-platelet or anti-coagulant drugs, like triflusal, clopidogrel and warfarin.~* Have allergies~* Smoking (including e-cigarettes and nicotine products)~* Alcohol misuse or intakes \>21 units/wk for men and \>15 units/wk for women or have a history of alcohol misuse~* Regularly consume oily fish and/or dietary supplements~* Planning to start or on a weight reducing regimen~* Intense aerobic exercise (\>20 min, three times a week)~* Females who are pregnant, lactating, or if of reproductive age and not using a reliable form of contraception (including abstinence)~* Have participated in another clinical trial within the last three months

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- Intervention (Type: ACTIVE_COMPARATOR): Fish oil capsules
- Placebo (Type: PLACEBO_COMPARATOR): High-oleic safflower oil capsules

Based on this trial design, predict the completion outcome and termination type (if applicable).